CD274 and neoplasm: In their study, the authors found that SK and BET inhibitor JQ1 which downregulate PD-L1 expression in tumor cells instead of directly blocking the binding between PD-1 and PD-L1 can synergistically inhibit tumor growth by activating ICD, repolarizing TAM2 and inhibiting glycolysis.